Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2017 March;42(1) > Minerva Endocrinologica 2017 March;42(1):1-7

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


eTOC

 

ORIGINAL ARTICLE  


Minerva Endocrinologica 2017 March;42(1):1-7

DOI: 10.23736/S0391-1977.16.02561-X

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Hypertriglyceridemic waist in type 1 diabetes patients: prevalence and related factors

Mercè FERNÁNDEZ-MIRÓ 1, 2, Juan J. CHILLARÓN 2, 3, 4 , Mercè ALBAREDA 5, Sara FONTSERÈ 2, 6, Cristina COLOM 1, Lluís VILA 5, Juan PEDRO-BOTET 2, 3, 4, Juana A. FLORES LE-ROUX 2, 3, 4, on behalf of TEST-T1D study group 

1 Department of Internal Medicine-Endocrinology and Nutrition, Centre d’Atenció Integral Dos de Maig, Barcelona, Spain; 2 Department of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain; 3 Department of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain; 4 IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; 5 Department of Endocrinology and Nutrition, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain; 6 Department of Medicine, Universitat Pompeu Fabra, Barcelona, Spain


PDF  


BACKGROUND: The hypertriglyceridemic waist has been linked to a higher number of cardiovascular risk factors and a greater probability of developing diabetes and cardiovascular disease. Around 50% of individuals with type 1 diabetes (T1D) are overweight or obese and triglyceridemia is associated with the onset of micro- and macrovascular complications.
METHODS: A cross-sectional study was conducted in men with T1D to assess the association between the prevalence of hypertriglyceridemic waist and cardiovascular risk factors and hypogonadism. Triglyceride levels + abdominal circumference taken together were stratified into quartiles to identify the hypertriglyceridemic waist phenotype.
RESULTS: One hundred and eighty-one male patients were included. An increased prevalence of hypogonadism and hypertension in parallel to increased triglyceride + waist circumference quartile was observed. Patients in the highest quartile had higher insulin resistance measured by estimated glucose disposal rate (eGDR 7.8±2.1 mg/kg-1.min-1 in 1st quartile vs. 5.8±1.8 mg/kg-1.min-1 in 4th quartile, P=0.000), insulin requirements, hip circumference, percentage of fat mass, glycosilated hemoglobin and total and LDL cholesterol as well as lower levels of total testosterone (27.24±9.3 nmol/L in 1st quartile vs. 17.4±8 nmol/L in 4th quartile, P=0.000) and HDL cholesterol. An inverse relationship was found between triglycerides + waist circumference and total testosterone levels (R=-0.367, P<0.0001).
CONCLUSIONS: The hypertriglyceridemic waist in men with T1D is associated with an atherogenic lipid profile, hypertension, worse metabolic diabetes control, increased insulin resistance and a higher prevalence of hypogonadism.


KEY WORDS: Hypertriglyceridemic waist - Diabetes mellitus, type 1 - Metabolic syndrome X

top of page

Publication History

Issue published online: January 5, 2017
Article first published online: November 8, 2016

Cite this article as

Fernández-Miró M, Chillarón JJ, Albareda M, Fontserè S, Colom C, Vila L, et al.; TEST-T1D study group. Hypertriglyceridemic waist in type 1 diabetes patients: prevalence and related factors. Minerva Endocrinol 2017;42:1-7. DOI: 10.23736/S0391-1977.16.02561-X

TEST-T1D study group

C. COLOM, M. FERNÁNDEZ, Department of Endocrinology and Nutrition, Centre d’Atenció Integral Dos de Maig, Barcelona, Spain; N. ASCOETA, D. BENAIGES, MJ. CARRERA, JJ. CHILLARÓN, E. CLIMENT, JA. FLORES LE-ROUX, A. GODAY, G. LLAURADÓ, L. MAÑÉ, A. MÁS, J. PEDRO-BOTET, J. PUIG, M. RENARD, E. SAGARRA, Department of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain; M. ALBAREDA, L. VILA, Department of Endocrinology and Nutrition, Hospital de Sant Joan Despí-Moisès Broggi, Barcelona, Spain; M. PRADOS, J. RIPOLLÉS, Department of Internal Medicine, Hospital de Martorell, Barcelona, Spain

Corresponding author e-mail

jChillaron@parcdesalutmar.cat